Register   |  Login
Promoting a sustainable livestock sector in Europe

IFAH – International Federation for Animal Health Europe

About IFAH-Europe
IFAH-Europe represents companies that research, develop and manufacture veterinary medicines in Europe. By protecting the health and welfare of more than 900 million animals across Europe, the veterinary medicines sector contributes to improving animal and public health, the production of safe, affordable and sustainable food, a sustainable environment. IFAH-Europe works to maintain a responsible and competitive market place, which stimulates innovation and allows wide access to safe, effective and affordable veterinary medicines.

IFAH-Europe aims to increase the awareness of the value animal health brings to society in terms of animal companionship, sustainable agriculture, safe food and improved public health. It wants to promote a predictable, harmonised, science-based and innovative market place for safe, effective and quality veterinary medicines for veterinarians, animal owners and farmers across Europe. Our membership includes both veterinary medicines companies and national animal health associations in Europe.

More information

Mrs. Roxane Feller

Mr. Peter Oostenbach

Twitter: @IFAHEurope

News Headlines

2nd White Paper of ATF - 06 February 2017
2016 was an important year for the European Horizon2020 research agenda setting. The ATF has worked all year long on a Second White Paper (2016) of suggested priorities for research and innovation for the Horizon2020 2018-2020 Work Programme.
Today, we are pleased to announce that the Second White Paper is now available.
This update of the First White Paper (2013) and Addendum (2014) was prepared by the Animal Task Force Presidency and members. It was largely inspired by a dialogue with key stakeholders and institutions in Europe and through the participation of various events related to the European research and innovation agenda and policy setting, to provide a consulted contribution from the animal production sector to the agenda setting for research and innovation.

2nd White Paper
Appendix 2 of the 2nd White Paper